We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Neuropharm | LSE:NPH | London | Ordinary Share | GB00B1NPJJ01 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.50 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMLLOY TIDMNPH RNS Number : 8607C Lloyds Banking Group PLC 20 November 2009 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION +--------------------------------------+--------------------------------------------+ | Name of person dealing (Note 1) | Lloyds Banking Group plc and its | | | subsidiaries | | | | +--------------------------------------+--------------------------------------------+ | Company dealt in | Neuropharm Group plc | | | | +--------------------------------------+--------------------------------------------+ | Class of relevant security to which | Ordinary 10p | | the dealings being disclosed | | | relate (Note 2) | | | | | +--------------------------------------+--------------------------------------------+ | Date of dealing | 19 November 2009 | +--------------------------------------+--------------------------------------------+ 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) +--------------------------------+-----------+----------+--------+---------+ | | Long | | Short | | +--------------------------------+-----------+----------+--------+---------+ | | Number | (%) | Number | (%) | +--------------------------------+-----------+----------+--------+---------+ | (1) Relevant securities | 3,033,071 | (9.618%) | | | +--------------------------------+-----------+----------+--------+---------+ | (2) Derivatives (other than | | | | | | options) | | | | | +--------------------------------+-----------+----------+--------+---------+ | (3) Options and agreements to | | | | | | purchase/sell | | | | | +--------------------------------+-----------+----------+--------+---------+ | Total | 3,033,071 | (9.618%) | | | +--------------------------------+-----------+----------+--------+---------+ (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) +--------------------------------+----------+--------+--------+-----+ | Class of relevant security: | Long | | Short | | +--------------------------------+----------+--------+--------+-----+ | | Number | (%) | Number | (%) | +--------------------------------+----------+--------+--------+-----+ | (1) Relevant securities | | | | | +--------------------------------+----------+--------+--------+-----+ | (2) Derivatives (other than | | | | | | options) | | | | | +--------------------------------+----------+--------+--------+-----+ | (3) Options and agreements to | | | | | | purchase/sell | | | | | +--------------------------------+----------+--------+--------+-----+ | Total | | | | | +--------------------------------+----------+--------+--------+-----+ (c) Rights to subscribe (Note 3) +------------------------+----------------------------------+ | Class of relevant | Details | | security: | | +------------------------+----------------------------------+ | | | +------------------------+----------------------------------+ 3. DEALINGS (Note 4) (a) Purchases and sales +------------------------------+---------------------------+---------------+ | Purchase/sale | Number of securities | Price per | | | | unit (Note 5) | +------------------------------+---------------------------+---------------+ | Sale | 400 | GBP0.150 | +------------------------------+---------------------------+---------------+ | | | | +------------------------------+---------------------------+---------------+ | | | | +------------------------------+---------------------------+---------------+ | | | | +------------------------------+---------------------------+---------------+ (b) Derivatives transactions (other than options) +------------+------------+-----------------+--------------+ | Product | Long/short | Number of | Price per | | name, e.g. | (Note 6) | securities | unit (Note | | CFD | | (Note 7) | 5) | | | | | | +------------+------------+-----------------+--------------+ | | | | | +------------+------------+-----------------+--------------+ (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying +-----------+-------------+------------+----------+-----------+--------+---------------+ | Product | Writing, | Number | Exercise | Type, | Expiry | Option | | name,e.g. | selling, | of | price | e.g. | date | money | | call | purchasing, | securities | | American, | | paid/received | | option | varying | to which | | European | | per unit | | | etc. | the option | | etc. | | (Note 5) | | | | relates | | | | | | | | (Note 7) | | | | | +-----------+-------------+------------+----------+-----------+--------+---------------+ | | | | | | | | +-----------+-------------+------------+----------+-----------+--------+---------------+ (ii) Exercising +--------------+------------------+-------------------------+ | Product | Number of | Exercise price per unit | | name, e.g. | securities | (Note 5) | | call option | | | +--------------+------------------+-------------------------+ | | | | +--------------+------------------+-------------------------+ (d) Other dealings (including new securities) (Note 4) +------------------------+---------------+-------------------+ | Nature of transaction | Details | Price per unit | | (Note 8) | | (if | | | | applicable) (Note | | | | 5) | +------------------------+---------------+-------------------+ | | | | +------------------------+---------------+-------------------+ 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. .............................................................................. N/A .............................................................................. Is a Supplemental Form 8 attached? (Note 9)NO +------------------------------------+---------------------+ | Date of disclosure | 20 November 2009 | | | | +------------------------------------+---------------------+ | Contact name | Matthew Wilson | | | | +------------------------------------+---------------------+ | Telephone number | 0113 235 7729 | | | | +------------------------------------+---------------------+ | If a connected EFM, name of | | | offeree/offeror with which | | | connected | | | | | +------------------------------------+---------------------+ | If a connected EFM, state nature | | | of connection (Note 10) | | | | | +------------------------------------+---------------------+ Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange END RETBMBJTMMBTBIL
1 Year Neuropharm Chart |
1 Month Neuropharm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions